Description
Lazolvan Tablets 30 mg. №50
Ingredients:
Each tablet contains 30 mg of ambroxol hydrochloride as the active ingredient.
Mechanism of Action:
Ambroxol, a mucolytic agent, works by breaking down and thinning mucus in the airways, facilitating its removal. It enhances surfactant production in the lungs, improving mucociliary clearance and reducing the susceptibility to respiratory infections.
Pharmacological Properties:
Ambroxol hydrochloride in Lazolvan tablets exerts mucolytic, anti-inflammatory, and antioxidant effects, contributing to the management of respiratory conditions.
Indications for Use:
Lazolvan tablets are indicated for respiratory diseases characterized by thick mucus, including acute and chronic bronchitis, bronchial asthma, and pneumonia.
Contraindications:
Avoid Lazolvan tablets in individuals with a known hypersensitivity to ambroxol or any other component of the product.
Side Effects:
Common side effects may include gastrointestinal disturbances, allergic reactions, and headache. Consult a healthcare provider if any adverse reactions occur.
Usage Instructions:
The recommended dosage for adults and children over 12 years is one tablet three times daily. Swallow the tablets whole with an adequate amount of water; do not crush or chew.
Benefits Compared to Analogues:
Lazolvan tablets offer similar efficacy to other mucolytic agents but with a preferable safety profile, making them a preferred choice for healthcare providers managing respiratory conditions.
Suitable Patient Groups:
Lazolvan tablets are suitable for use in adults, adolescents, and children over 12 years under appropriate medical supervision.
Storage and Shelf Life:
Store Lazolvan tablets in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use expired tablets.
Packaging Description:
Lazolvan tablets are available in a pack containing 50 tablets of 30 mg strength each.
Clinical Evidence and Proven Effectiveness:
Lazolvan tablets have undergone rigorous clinical trials demonstrating their efficacy in respiratory conditions. Studies have highlighted the mucolytic, anti-inflammatory, and antioxidant properties of ambroxol, supporting its role in managing respiratory diseases.
